V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214772 | 20168307 | 1.7 | 63 | null | 2021-06-18 | 2021-07-30 | GEMCITABINE + NAB PACLITAXEL | 02 | null | CAPECITABINE + CARBOPLATIN | 100270949 |
| 20214773 | 20168308 | 1.8 | 59.9 | Palliative (P) | 2021-01-29 | 2022-01-10 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101367434 |
| 20214792 | 20168309 | 0 | 60 | Palliative (P) | 2018-03-29 | 2018-06-19 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101407417 |
| 20214806 | 20168310 | 1.82 | 75.8 | Palliative (P) | 2022-04-29 | 2022-05-02 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100350957 |
| 20214822 | 20168311 | 1.8 | 77.8 | Neo-adjuvant (N) | 2021-11-13 | 2021-11-23 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101704048 |
| 20214824 | 20168312 | 1.8 | 67.8 | Palliative (P) | 2021-01-10 | 2021-01-10 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CAPECITABINE + CARBOPLATIN | 101510025 |
| 20214825 | 20168313 | 1.82 | 100 | Neo-adjuvant (N) | 2021-01-06 | 2021-06-02 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100335688 |
| 20214831 | 20168314 | 1.63 | 79.9 | Palliative (P) | 2022-04-03 | 2022-04-23 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100607024 |
| 20214833 | 20168315 | 1.77 | 90.4 | Palliative (P) | 2017-11-09 | 2017-11-23 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100260972 |
| 20214834 | 20168316 | 1.74 | 91.8 | null | 2021-04-15 | 2021-05-06 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100900742 |
| 20214835 | 20168317 | 1.72 | 46.2 | null | 2019-09-14 | 2019-10-29 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101479784 |
| 20214836 | 20168318 | 1.6 | 65.4 | Adjuvant (A) | 2020-01-31 | 2020-02-03 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101491028 |
| 20214839 | 20168319 | 1.74 | 0 | Palliative (P) | 2017-05-19 | 2017-05-24 | HCX | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100794594 |
| 20214843 | 20168320 | 1.56 | 72.4 | null | 2018-03-07 | 2018-03-20 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100155282 |
| 20214844 | 20168321 | 1.62 | 72.3 | Palliative (P) | 2019-01-17 | 2019-01-17 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101295846 |
| 20214847 | 20168322 | 1.5 | 80.2 | Palliative (P) | 2019-03-26 | 2019-03-26 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101719580 |
| 20214852 | 20168323 | 1.82 | 82.9 | null | 2017-01-12 | 2017-01-15 | HCX (Cape + Cisp + Tras) - Load | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101194972 |
| 20214853 | 20168324 | 1.71 | 74 | Curative (C) | 2018-10-27 | 2018-11-28 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101144697 |
| 20214859 | 20168325 | 1.52 | 55.5 | Palliative (P) | 2016-07-22 | 2022-05-15 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100718005 |
| 20214862 | 20168326 | null | 83.5 | Palliative (P) | 2019-07-19 | 2019-07-20 | GEMCITABINE + Paclitaxel Albumin | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100004614 |
| 20214868 | 20168327 | 1.64 | 98 | Palliative (P) | 2019-02-06 | 2019-02-23 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101141735 |
| 20214882 | 20168328 | 1.63 | 93.2 | null | 2018-11-24 | 2019-01-02 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100490931 |
| 20214891 | 20168329 | 1.62 | 77.5 | Curative (C) | 2019-02-20 | 2019-02-23 | HCX (Cape + Cisp + Tras) - Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101751699 |
| 20214893 | 20168330 | 1.68 | 54 | null | 2016-12-29 | 2017-01-26 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100347945 |
| 20214897 | 20168331 | 1.82 | 57.2 | Palliative (P) | 2020-11-22 | 2021-05-07 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100016782 |
| 20214901 | 20168332 | 1.64 | 80.5 | Palliative (P) | 2016-08-28 | 2016-09-19 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100939900 |
| 20214907 | 20168333 | 1.78 | 83 | Neo-adjuvant (N) | 2021-05-25 | 2021-06-27 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100571351 |
| 20214909 | 20168334 | 1.61 | 77 | Adjuvant (A) | 2018-07-30 | 2018-08-15 | Cape+Cisplatin+Trastuzumab Load | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100769305 |
| 20214912 | 20168335 | 1.74 | 55 | null | 2017-04-28 | 2017-04-28 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100294619 |
| 20214914 | 20168336 | 1.76 | 41 | Palliative (P) | 2018-03-20 | 2019-08-21 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101577670 |
| 20214944 | 20168337 | 1.8 | 74 | Palliative (P) | 2020-10-18 | 2020-10-18 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CAPECITABINE + CARBOPLATIN | 101257816 |
| 20214945 | 20168338 | 1.82 | 77 | null | 2015-02-15 | 2016-10-30 | Cape+Cisplatin+Trastuzumab Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101395902 |
| 20214946 | 20168339 | 1.63 | 77.7 | Palliative (P) | 2021-12-04 | 2021-12-15 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101338200 |
| 20214947 | 20168340 | 1.76 | 75.8 | null | 2018-05-11 | 2018-06-07 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101136537 |
| 20214952 | 20168341 | 1.68 | 81.9 | Palliative (P) | 2019-07-18 | 2019-08-02 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100014991 |
| 20214955 | 20168342 | 1.55 | 68.9 | Palliative (P) | 2019-11-20 | 2019-12-12 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101504337 |
| 20214966 | 20168343 | 1.74 | 77.9 | Palliative (P) | 2020-03-26 | 2020-03-26 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101333253 |
| 20214972 | 20168344 | 1.8 | 56.4 | Neo-adjuvant (N) | 2017-11-22 | 2018-06-23 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | Y | GEMCITABINE + NAB-PACLITAXEL | 101139540 |
| 20214976 | 20168345 | 1.72 | 56.7 | Palliative (P) | 2020-11-17 | 2020-11-29 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100942694 |
| 20214982 | 20168346 | 1.78 | 42.5 | Palliative (P) | 2016-10-03 | 2016-11-19 | HCX | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100293986 |
| 20214984 | 20168347 | 1.76 | 77.6 | null | 2022-01-19 | 2022-01-19 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101056184 |
| 20214985 | 20168348 | 1.75 | 98.9 | null | 2019-05-04 | 2019-05-13 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101837086 |
| 20214995 | 20168349 | 1.82 | 63.6 | Palliative (P) | 2016-03-06 | 2018-07-24 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101342111 |
| 20215003 | 20168350 | 1.59 | 72.9 | Palliative (P) | 2017-06-22 | 2017-06-25 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101564000 |
| 20215005 | 20168351 | 1.72 | 60 | Palliative (P) | 2017-03-14 | 2017-03-23 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101757701 |
| 20215007 | 20168352 | 1.81 | 87.8 | Palliative (P) | 2017-05-10 | 2017-05-10 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100540303 |
| 20215011 | 20168353 | 1.81 | 71 | Palliative (P) | 2020-01-07 | 2020-02-29 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100497948 |
| 20215017 | 20168354 | 1.77 | 69 | Palliative (P) | 2017-09-21 | 2017-10-12 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101634349 |
| 20215020 | 20168355 | 1.72 | 50 | null | 2021-04-23 | 2021-05-03 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101439653 |
| 20215022 | 20168356 | 1.51 | 69.5 | Adjuvant (A) | 2020-10-01 | 2020-10-22 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100813707 |